Cargando…
Functional EpoR Pathway Utilization Is Not Detected in Primary Tumor Cells Isolated from Human Breast, Non-Small Cell Lung, Colorectal, and Ovarian Tumor Tissues
Several clinical trials in oncology have reported increased mortality or disease progression associated with erythropoiesis-stimulating agents. One hypothesis proposes that erythropoiesis-stimulating agents directly stimulate tumor proliferation and/or survival through cell-surface receptors. To tes...
Autores principales: | Patterson, Scott D., Rossi, John M., Paweletz, Katherine L., Fitzpatrick, V. Dan, Begley, C. Glenn, Busse, Leigh, Elliott, Steve, McCaffery, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373902/ https://www.ncbi.nlm.nih.gov/pubmed/25807104 http://dx.doi.org/10.1371/journal.pone.0122149 |
Ejemplares similares
-
Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021) -
Epo Receptors Are Not Detectable in Primary Human Tumor Tissue Samples
por: Elliott, Steve, et al.
Publicado: (2013) -
EpoR stimulates rapid cycling and larger red cells during mouse and human erythropoiesis
por: Hidalgo, Daniel, et al.
Publicado: (2021) -
The Effects of Curcumae Longae Radix, Curcuma phaeocaulis Radix and Their Processed Products on Epo/EpoR Pathway and CD62p
por: Chen, Zhimin, et al.
Publicado: (2018) -
Local YB-1, Epo, and EpoR concentrations in fractured bones: results from a porcine model of multiple trauma
por: Bläsius, Felix Marius, et al.
Publicado: (2023)